Shares of BeyondSpring Inc. (NASDAQ:BYSI - Get Free Report) were down 13.8% during trading on Monday . The stock traded as low as $1.87 and last traded at $1.88. Approximately 44,776 shares changed hands during mid-day trading, an increase of 40% from the average daily volume of 31,918 shares. The stock had previously closed at $2.18.
BeyondSpring Stock Down 1.5%
The company's 50 day simple moving average is $2.22 and its 200 day simple moving average is $1.82.
BeyondSpring (NASDAQ:BYSI - Get Free Report) last released its earnings results on Monday, May 12th. The company reported ($0.06) EPS for the quarter.
About BeyondSpring
(
Get Free Report)
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Recommended Stories
Before you consider BeyondSpring, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.
While BeyondSpring currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access